ArticleArchives of rheumatology2025
Thoracic Ultrasound in Assessment of the Pleura in Connective Tissue Disease.
Article in Archives of rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Aims: To investigate the use of thoracic ultrasound (US) in the assessment of the pleura in connective tissue disease (CTD). Materials and Methods: The clinical, radiologic, and demographic data were recorded f rom patients who were diagnosed as having CTD at least 1 year before the study. Thoracic US was performed for pleural assessments in all patients who met the inclusion criteria. The thickness of the parietal and visceral layers of the pleura and pleural space was measured in milli-meters and recorded in both the CTD and healthy control groups, and data f rom the CTD group were compared with those f rom the healthy control group. Results: A total of 86 participants, 44 (51.2%) with CTD and 42 (48.8%) healthy volunteers, were included in the study. There were 37 (84.1%) females with a mean age of 55.1 ± 11.1 years in the CTD group and 23 (54.8%) females with a mean age of 56 ± 11.8 years in the control group. In the CTD group, the mean parietal pleural thickness, visceral pleural thickness, and pleural space were 0.61 ± 0.16 mm, 0.61 ± 0.17 mm, and 0.77 ± 0.5 mm, respectively, and in the control group, these values were 0.42 ± 0.08 mm, 0.44 ± 0.09 mm, and 0.47 ± 0.15 mm, respectively (P < .001). Conclusion: Pleural thickness was increased in patients with CTD com-pared with healthy controls. The lungs are among the target organs in CTD, and US is a non-invasive and radiation-f ree imaging modality that can be used in the assessment of pleural involvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.